Related Articles
What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
The Key to Early Rheumatoid Arthritis
The conundrum of classification versus diagnosis
Interferon Score Predicts AI-CTDs
People with autoimmune connective tissue diseases produce antibodies against nuclear antigens up to 10 years before they develop clinical features. Anti-nuclear antibodies (ANAs) are also very common, and a small percentage of ANA-positive patients progress to clinical autoimmunity. The question: Is there a reliable way to screen at-risk patients before they develop active autoimmunity and…
Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease
A review of data on antinuclear antibodies and tests for rheumatoid arthritis